We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




FIND Receives Grant for Diagnostics from Dutch Government

By Labmedica staff writers
Posted on 29 Nov 2006
Print article
The Dutch Government has approved the Foundation for Innovative New Diagnostics' (FIND, Geneva, Switzerland) application for a grant to develop improved diagnostics for tuberculosis (TB), the human immunodeficiency virus (HIV), and malaria.

The grant amounts to U.S.$10.1 million over a period of four years, beginning November 2006. The grant is to finance gaps in existing plans and programs to develop simple, accurate, and rapid molecular tests for TB, HIV, and malaria.

The point-of-care products to be developed by FIND will include chemical sensor arrays for the detection of volatile compounds in the sputum of TB infected individuals, an improved lateral-flow assay to diagnose malaria in a finger-prick blood sample, and a lateral-flow assay to diagnose TB by detecting Mycobacterium tuberculosis (MTb) antigens in urine.

FIND also plans to develop a simple nucleic acid amplification test for the detection of TB in urine, a simple amplification test for the detection of malaria from whole blood, and a hands-free automated nucleic acid amplification test (NAAT) for HIV viral load in blood at first-referral laboratory level.

In the first quarter of 2007 FIND plans to launch a project on laboratory preparedness for the introduction of new technologies in Uganda, with the aim to strengthen laboratory diagnostic services in that country.




Related Links:
FIND
New
Gold Member
Syphilis Screening Test
VDRL Antigen MR
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Silver Member
Apolipoprotein A-I Assay
Apo A-I Assay
New
Nuclear Matrix Protein 22 Test
NMP22 Test

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.